Skip to main content
. Author manuscript; available in PMC: 2017 May 15.
Published in final edited form as: Clin Cancer Res. 2015 Dec 15;22(10):2396–2404. doi: 10.1158/1078-0432.CCR-15-1468

Figure 1.

Figure 1

Overall survival curves for patients with high, intermediate, and low levels of SMARCA4 (212520_s_at) expression in the Director’s Challenge Study. (A) all patients; (B) patients without adjuvant treatment. Log-rank P-values are shown.